Objetivo: O câncer de pulmão (CP) é o tipo mais letal de câncer na população mundial e representa um importante problema de saúde pública. A tuberculose é outra causa significativa de morbidade e mortalidade, especialmente em países em desenvolvimento. A ocorrência de tuberculose pulmonar e CP no mesmo paciente, simultaneamente ou não, tem sido descrita em diversas séries de casos e estudos de caso-controle. O objetivo deste estudo foi descrever as características de pacientes com tuberculose e CP, com apresentação simultânea ou sequencial. 
Introduction
Lung cancer (LC) is the most deadly type of cancer and represents a major public health problem worldwide. It is the leading cause of cancer-related death in Brazil and in the world, with 1.3 million deaths annually. (1) Another major cause of morbidity and mortality, especially in developing countries, is tuberculosis. (2) It has been suggested that inflammation and pulmonary fibrosis caused by tuberculosis can induce genetic damage, which can increase LC risk. (3) (4) (5) The increased occurrence of LC in patients with tuberculosis can also be related to infection-induced immunosuppression. (6) In contrast, cancer-induced or chemotherapy-induced immunosuppression can also lead to increased rates of tuberculosis reactivation in patients with solid tumors. (7) The simultaneous or sequential occurrence of pulmonary tuberculosis and LC in the same patient has been reported in various case series and case-control studies. (8) (9) (10) (11) (12) (13) The association between these two diseases is important, since both are quite prevalent and have a major impact on public health. In addition, considering that one study (10) demonstrated that the association between tuberculosis and LC varies in different ethnic groups and also in different regions, it is important to know the characteristics of these cases in Brazil. Therefore, the objective of this study was to describe the clinical characteristics of patients with pulmonary tuberculosis and LC.
Methods
This was a cross-sectional study, involving retrospective data collection, conducted in order to determine the characteristics of patients with tuberculosis and LC who were treated at the Hospital de Clínicas de Porto Alegre (HCPA, Porto Alegre Hospital de Clínicas), located in the city of Porto Alegre, southern Brazil. The HCPA is a general tertiary university hospital with 750 beds and approximately 30,000 hospitalizations annually. The HCPA Research Ethics Committee granted permission for access to patient records. A waiver of informed consent was obtained, and the researchers signed a confidentiality agreement.
The study involved patients diagnosed with tuberculosis and LC, either simultaneously or sequentially. We performed a search of the files of the pulmonology outpatient clinics for patients with tuberculosis and LC, and the electronic medical records of these patients were reviewed. A standardized form was completed for each patient included in the study. Demographic data and data relating to the diagnoses of tuberculosis and LC were collected, as were pulmonary function test results.
The diagnosis of pulmonary tuberculosis was based on consensus criteria (14) : The diagnoses of LC and tuberculosis were classified by timing as follows: simultaneous-when the diagnoses of tuberculosis and LC occurred simultaneously or when the time between the two diagnoses was < 2 months; sequential (LC first)-when tuberculosis was diagnosed ≥ 2 after LC diagnosis and within 12 months of completion of LC treatment; sequential (tuberculosis first)-when LC is diagnosed ≥ 2 months after tuberculosis diagnosis, indefinitely, because of the possibility of scar cancer. (10, 15, 16) The data were entered into Microsoft Excel spreadsheets, after which they were processed and analyzed with the Statistical Package for the Social Sciences, version 18.0 (SPSS Inc., Chicago, IL, USA). We carried out a descriptive analysis of the study variables. Quantitative data are presented as mean ± SD. Qualitative data are expressed as n (%).
Results
The study involved 24 patients diagnosed with tuberculosis and LC between 2009 and 2012. The principal characteristics of the patients are shown in Table 1 . In 10 of the 24 patients, the diagnoses of tuberculosis and LC occurred simultaneously, whereas, in 14, tuberculosis was diagnosed before LC. The median time between the two diagnoses was 5 years (interquartile range: 1-30 years). Tuberculosis treatment was as follows: a regimen consisting of rifampin, isoniazid, and pyrazinamide, in 11 patients (45.8%); and a regimen consisting of rifampin, isoniazid, pyrazinamide, and ethambutol, in 7 (29.2%). In 6 patients (25.0%), data on treatment regimen were either not provided or unavailable. Only 1 patient (4.2%) reported noncompliance with tuberculosis treatment, 3 (12.5%) died, and 16 (66.7%) were discharged as cured. For 5 (20.8%) of the patients, no treatment outcome data were available.
The mean age at LC diagnosis was 62.8 ± 10.6 years. Of the 24 patients, 7 (29.2%) presented with distant metastases at diagnosis; of those 7 patients, 71% were diagnosed with LC and tuberculosis simultaneously. The following LC treatments were performed: radiotherapy alone, in 6 patients (25.0%); chemotherapy and radiotherapy, in 4 (16.7%); surgery alone, in 3 (12.5%); chemotherapy alone, 2 (8.3%); surgery and radiotherapy, in 2 (8.3%); surgery and chemotherapy, in 2 (8.3%); and supportive treatment alone, in 5 (20.8%).
Discussion
In this study, we described the characteristics of 24 patients developing tuberculosis and LC, either simultaneously or sequentially. Tuberculosis was diagnosed before LC in most of the patients, and in none of the cases was LC diagnosed before tuberculosis. Non-small cell lung cancer, especially adenocarcinoma, was the most common histological type.
The coexistence of pulmonary tuberculosis and LC was first described in 1810, and it was demonstrated histologically a few years later. (9) Since then, several studies on this association have been published, most of which are case series and case-control studies. (8) (9) (10) (11) (12) (13) However, it has always been questioned whether this association was casual or whether it could be explained by a plausible biological mechanism. One hypothesis would be that inflammation associated with infections can contribute to carcinogenesis. (4) Reactive oxygen or nitrogen species produced by activated neutrophils can bind to the DNA, inducing genetic damage and neoplastic transformation. (17, 18) In fact, it has been shown that alterations of the fragile histidine triad gene might be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis. (19) (20) (21) In addition, during tissue repair, there is increased cell proliferation and angiogenesis, and the epithelium is more prone to metaplasia. Furthermore, carcinogens concentrate preferentially in hyperactive areas to induce neoplastic changes. (22, 23) The cases described here are similar to those reported in previous studies. (8) (9) (10) (11) (12) (13) Adenocarcinoma was the most common histological type in our case series. In a meta-analysis (10) of 37 case-control studies and 4 cohort studies, the association between tuberculosis and LC was significant for adenocarcinoma (relative risk = 1.6), but not for epidermoid carcinoma or small cell carcinoma. In a case series of LC in Japan, (24) adenocarcinoma was also the most common cancer. Another study (9) demonstrated that all scar carcinomas were adenocarcinomas, and that, even in cases in which there was no proximity between the scar and the neoplasm, adenocarcinoma was the most common histological type. cancer. In a case series conducted in Japan, (24) the diagnoses were concomitant in 6 patients, tuberculosis was diagnosed before LC in 5 cases, and LC was diagnosed before tuberculosis in the remaining 5. It is possible that tuberculosis was diagnosed before LC more frequently because of a reverse causality bias, i.e., an occult cancer can reduce immunity and lead to reactivation of latent tuberculosis. Therefore, tuberculosis can present clinically before LC. (16, 19) Our study has limitations that need to be considered. The major one is that the cases were identified retrospectively on the basis of a search of the files of the specialized outpatient clinics at our hospital. Retrospective studies are at risk of selection bias (cases lost to follow-up) and measurement bias (data obtained from medical records). We should also consider the Berkson bias, in which patients with an index diagnosis are more likely to be diagnosed with another disease than are those without an index diagnosis. For instance, patients with tuberculosis, at follow-up chest X-ray, are more prone to be diagnosed with cancer than are those not diagnosed with tuberculosis. (27) Nevertheless, because the occurrence of tuberculosis and LC, either simultaneously or not, may have different characteristics according to ethnic group and region, (10) it is relevant that cases identified locally be described. In addition, the importance of these cases lies in the fact that patients diagnosed with tuberculosis should be advised to avoid lung carcinogens, such as tobacco smoking, as much as possible, since these agents contribute to a substantial increase in LC risk.
In conclusion, the present study demonstrated that most of the patients with tuberculosis and LC were smokers, and that tuberculosis was diagnosed either before or simultaneously with LC. Non-small cell lung cancer, especially adenocarcinoma, was the most common histological type.
The vast majority of the patients described here were smokers or former smokers. Despite the cumulative effects of tobacco as a carcinogen, the relationship between pulmonary tuberculosis and LC persists even after control for smoking, with cancer risk being 2.5-fold higher among patients with tuberculosis. (6, 8, 25) A meta-analysis (10) corroborated this evidence, showing that the association between tuberculosis and LC was not due to the effects of smoking, because, when considering only nonsmoking patients, there was a 1.78-fold increase in LC risk among patients with tuberculosis. That same metaanalysis demonstrated that the association between tuberculosis and LC was not due to the time since diagnosis of tuberculosis. Because the initial symptoms of LC can be mistaken for the symptoms of pulmonary tuberculosis, that analysis was restricted to studies in which tuberculosis was diagnosed more than 1 year before cancer, in order to minimize this bias. The studies were grouped by time between the two diagnoses (1-5, 6-10, 11-20, and more than 20 years). The increase in cancer risk was higher in the first 5 years after tuberculosis; diagnosis; however, the risk remained 1.99-fold higher among those for whom the time between the diagnoses was more than 20 years. This was true in our sample as well, given that the median time between the diagnoses of tuberculosis and LC was 5 years (interquartile range: 1-30 years). Another, more recent study (11) showed that LC risk was highest in the 2-year window after tuberculosis diagnosis (OR = 5.01) but remained elevated even 2 years after diagnosis (OR = 1.53).
Approximately 30% of the patients presented with distant metastases at LC diagnosis. Of those, 71% were diagnosed with LC and tuberculosis simultaneously. Another case series found that 50% of the patients had stage IV LC. (24) Because the initial symptoms of these two diseases are similar, it should be considered that there can be a delay in the diagnosis of either condition and, consequently, patients can present with either LC or tuberculosis at a more advanced stage. (26) In none of our reported cases was LC diagnosed before pulmonary tuberculosis. In contrast, in a recent, retrospective case-control study (15) involving 36 patients with LC, 10 (27.8%) were diagnosed with tuberculosis and cancer concomitantly, whereas 26 (72.2%) were diagnosed with tuberculosis after being diagnosed with
